Researchers have created an AI model that analyses the citations of studies, predicting their potential for eventual clinical application.
List view / Grid view
Filter the results
A new cell therapy has been tested in patients with liver cirrhosis and found no significant adverse effects.
The FDA has given the designation to niraparib for the treatment of gene-mutated castration-resistant prostate cancer.
The FDA has announced its approval of Descovy, a PrEP method therapy, to reduce the risk of HIV-1 infection from sex.
The FDA has given a complete response letter to AstraZeneca for its PT010 treatment, regarding its New Drug Application.
The FDA grants Orphan Drug Designation to treatments for rare diseases in R&D; here are the 10 most recent for oncologic conditions.
The cannabidiol-based treatment EPIDYOLEX has been granted marketing authorisation from the European Commission.
A Biologics License Application and priority review has been approved by the FDA for an investigational Ebola vaccine.
Cosentyx®, a treatment for an inflammatory disease has met its primary endpoints in patients during a Phase III trial.
Kenya has become the third African country to introduce the world’s first malaria vaccine into the country, in a phased pilot programme.
The seven centres will aid disease research and clinical development, improving access to patient data for studies.
According to a new report, blockchain technology in the healthcare market size is set to increase exponentially.
The Kymriah (tisagenlecleucel) treatment has received a positive appraisal from the Scottish Medicines Consortium, after EMA approval last year.